<VariationArchive VariationID="9766" VariationName="XK, 1-BP DEL" VariationType="Deletion" Accession="VCV000009766" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-17" DateCreated="2013-04-04" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="24805" VariationID="9766">
      <GeneList>
        <Gene Symbol="XK" FullName="X-linked Kx blood group antigen, Kell and VPS13A binding protein" GeneID="7504" HGNC_ID="HGNC:12811" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xp21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="37685791" stop="37732130" display_start="37685791" display_stop="37732130" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="37545132" stop="37591382" display_start="37545132" display_stop="37591382" Strand="+" />
          </Location>
          <OMIM>314850</OMIM>
        </Gene>
      </GeneList>
      <Name>XK, 1-BP DEL</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.2-p21.1</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>1-BP DEL</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="314850.0003" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff could not confirm the sequence change on a current reference sequence after review of PubMed 8619554.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="XK, 1-BP DEL AND McLeod neuroacanthocytosis syndrome" Accession="RCV000010420" Version="4">
        <ClassifiedConditionList TraitSetID="2723">
          <ClassifiedCondition DB="MedGen" ID="C0398568">McLeod neuroacanthocytosis syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1996-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1996-05-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2024-03-16">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">8619554</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2723" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10628" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NEUROACANTHOCYTOSIS, MCLEOD TYPE</ElementValue>
                <XRef Type="MIM" ID="300842" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MCLEOD PHENOTYPE</ElementValue>
                <XRef Type="MIM" ID="300842" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">McLeod neuroacanthocytosis syndrome</ElementValue>
                <XRef ID="McLeod+neuroacanthocytosis+syndrome/8791" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018945" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">McLeod syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked McLeod syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MCLDS</ElementValue>
                <XRef Type="MIM" ID="300842" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">McLeod neuroacanthocytosis syndrome (designated as MLS throughout this review) is a multisystem disorder with central nervous system (CNS), neuromuscular, cardiovascular, and hematologic manifestations in males: CNS manifestations are a neurodegenerative basal ganglia disease including movement disorders, cognitive alterations, and psychiatric symptoms. Neuromuscular manifestations include a (mostly subclinical) sensorimotor axonopathy and muscle weakness or atrophy of different degrees. Cardiac manifestations include dilated cardiomyopathy, atrial fibrillation, and tachyarrhythmia. Hematologically, MLS is defined as a specific blood group phenotype (named after the first proband, Hugh McLeod) that results from absent expression of the Kx erythrocyte antigen and weakened expression of Kell blood group antigens. The hematologic manifestations are red blood cell acanthocytosis and compensated hemolysis. Alloantibodies in the Kell and Kx blood group system can cause strong reactions to transfusions of incompatible blood and severe anemia in affected male newborns of Kell-negative mothers. Females heterozygous for XK pathogenic variants have mosaicism for the Kell and Kx blood group antigens. Although they usually lack CNS and neuromuscular manifestations, some heterozygous females may develop clinical manifestations including chorea or late-onset cognitive decline.</Attribute>
                <XRef ID="NBK1354" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000500117" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507942" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509072" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509486" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511451" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10731" />
                <XRef ID="10731" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301528</ID>
                <ID Source="BookShelf">NBK1354</ID>
              </Citation>
              <XRef ID="59306" DB="Orphanet" />
              <XRef ID="C0398568" DB="MedGen" />
              <XRef ID="MONDO:0018945" DB="MONDO" />
              <XRef Type="MIM" ID="300842" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="30646" SubmissionDate="2011-10-24" DateLastUpdated="2024-03-16" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="314850.0003_MCLEOD SYNDROME" title="XK, 1-BP DEL_MCLEOD SYNDROME" />
        <ClinVarAccession Accession="SCV000030646" DateUpdated="2024-03-16" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a female with McLeod syndrome (MCLDS; 300842), Ho et al. (1996) demonstrated a novel 1-bp deletion in exon 2 of the XK gene at codon 90, creating a frameshift that results in premature termination of translation and elimination of 80% of the predicted XK protein. The mutation was found in a 51-year-old woman who presented with cognitive impairment, chorea tics, and areflexia due to an axonal peripheral neuropathy. This woman had marked skewing of X inactivation. The authors pointed out the similarity of the clinical features in advanced cases of McLeod syndrome to those of choreoacanthocytosis (200150).</Attribute>
              <Citation>
                <ID Source="PubMed">8619554</ID>
              </Citation>
              <XRef DB="OMIM" ID="300842" Type="MIM" />
              <XRef DB="OMIM" ID="200150" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="XK" />
          </GeneList>
          <Name>XK, 1-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="314850.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MCLEOD SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="30646" TraitType="Disease" MappingType="Name" MappingValue="MCLEOD SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0398568" Name="McLeod neuroacanthocytosis syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

